PDCO minutes of the 21-24 July 2026 meeting
PDCO minutes of the 21-24 July 2026 meeting
PDCO minutes of the 21-24 July 2026 meeting
Member states contact points for review of national implementation of quick response (QR) codes of veterinary medicinal products authorised via the centralised (CP), mutual recognition (MRP), decentralised procedures (DCP) and national procedures
INS-GCP-1 procedure for coordinating good-clinical-practice inspections requested by the CHMP
Clinical requirements for medicines intended for the treatment of sickle cell disease
Draft guideline on the clinical requirements for medicines intended for the treatment of sickle cell disease
Clinical requirements for medicines intended for the treatment of thalassaemia
Draft guideline on the clinical requirements for medicines intended for the treatment of thalassaemia
Agenda of the HMPC meeting 22-24 September 2026
First European Medicines Agency (EMA) and Active Pharmaceutical Ingredients Committee (APIC) bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, from 2 September 2026, 15:30 (CEST) to 2 September 2026, 17:30 (CEST)
Human medicines European public assessment report (EPAR): Fintepla, fenfluramine, Date of authorisation: 18/12/2020, Revision: 20, Status: Authorised